Human Tissue Authority to Present at Biobanking Conference, London

LONDON - May 9, 2013 - PRLog -- Following on from this, the key ethical and regulatory considerations will be addressed by Shaun Griffin, Director of Communications, HRA & HTA, in a unique presentation at SMi’s 3rd annual Biobanking conference this June.
Presentation highlights will include:

• The legal and regulatory requirements for biobanking (both for research and patient treatment)
• Ethical requirements for Biobanking
• How the HTA and HRA work together, and win others, to support biobanking in the UK
• What meeting the regulatory and ethical requirements means from a practicle perspective
• Emerging Issues

Biobanking 2013 will bring together key solution providers and potential clients affiliated with pharmaceutical companies and Biobanking institutions alike therefore providing an excellent platform for communication within the biobanking community.

"The Smi Biobanking conference brings together key opinion leaders in the rapidly evolving field of biobanking. .... The Biobanking conference will inform and guide our response to these challenges and will be provide an invaluable opportunity to understand and share best practice." - Brian Thompson, Director of Research and Development, Nottingham University

Attendees will:

• Discover how to build and develop a successful biobanking infrastructure
• Discuss key ethical and regulatory considerations with input from the Human Research Authority
• Cover topics that expose commercial opportunities for future investments
• Explore Strategic Tissue Repository Alliances Through Unified Methods (STRATUM) with Julie Corfield, Director at Areteva, who will also be leading a roundtable discussion on The Business of Biobanking; how can it be made more cost effective and streamlined?
• Discuss how to promote availability and maximise value from biospecimen collections

Speakers at the event include:

• Julie Corfield, Director, Areteva
• Janine Swifka, Biobank Scientist, Bayer
• Paul Whittaker, Director, Novartis
• Shaun Griffin, Director of Communications, HRA & HTA
• Kirstin Goldring, Biobank Facilitator, UCL Biobank
• Ma’n H. Zawati, Academic Associate, Centre of Genomics and Policy, McGill university

For further information visit the event homepage at:
www.smi-online.co.uk/goto/2013bio-banking-event49.asp